Effect of a Myopia Prediction System on Myopia Prevention and Control

Launched by ZHONGSHAN OPHTHALMIC CENTER, SUN YAT-SEN UNIVERSITY · Oct 8, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new way to help prevent and control myopia, which is a common vision problem often called nearsightedness. Myopia is becoming more common among children, especially in China, and current methods like eye exams and educational programs aren't enough to stop it from getting worse. The trial will use a special system powered by artificial intelligence (AI) to predict which children are at risk of developing severe myopia. By identifying those at risk, the hope is to encourage better eye care and treatment to protect their vision in the future.

To participate in this trial, children aged 9 to 11 years who have had an eye exam in the past year can join, as long as they and their guardians agree to be part of the study. However, kids with severe myopia or certain eye and health conditions won't be eligible. Participants will be monitored over the course of a year to see how well the myopia prediction system works in reducing the risk of worsening vision. This trial is not yet recruiting participants, but it aims to offer insights into improving eye care for children.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The participant and their guardian voluntarily signed the informed consent form
• • Has the record of eye refraction examination in the past year
• • Aged 9 to 11 years, regardless of gender
• Exclusion Criteria:
• • High myopia(spherical equivalent ≤ -6.00 D)
• • Ocular diseases other than myopia (e.g., strabismus, amblyopia, congenital cataract, juvenile glaucoma, retinal diseases).
• • Systemic diseases that may affect vision or visual development (e.g., diabetes or other endocrine disorders, cardiovascular or respiratory diseases, Down syndrome)